Vista Investment Partners’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.21M Sell
42,368
-14,027
-25% -$373K 0.31% 75
2026
Q2
$1.36M Sell
56,395
-9,036
-14% -$236K 0.34% 73
2026
Q1
$1.84M Sell
65,431
-2,840
-4% -$75.6K 0.49% 64
2025
Q4
$1.7M Sell
68,271
-1,342
-2% -$33.8K 0.44% 70
2025
Q3
$1.77M Buy
69,613
+48,900
+236% +$1.21M 0.5% 59
2025
Q2
$502K Sell
20,713
-856
-4% -$20K 0.14% 105
2025
Q1
$547K Sell
21,569
-9
-0% -$236 0.17% 103
2024
Q4
$572K Sell
21,578
-48,220
-69% -$1.31M 0.18% 103
2024
Q3
$2.02M Sell
69,798
-7,254
-9% -$212K 0.65% 53
2024
Q2
$2.16M Sell
77,052
-2,180
-3% -$60K 0.72% 46
2024
Q1
$2.2M Buy
79,232
+4,015
+5% +$111K 0.75% 45
2023
Q4
$2.17M Buy
+75,217
New +$2.27M 0.79% 46

Other funds holding PFE

Vista Investment Partners's PFE Position: Q3 2026 in Review

Vista Investment Partners reduced its Pfizer (PFE) stake by 25% in Q3 2026, selling an estimated $373K and leaving 42,368 shares worth $1.21M. The position accounts for 0.31% of the portfolio, ranked #75.

Vista Investment Partners first reported a position in PFE in Q4 2023 and has held it in 12 quarters since. The position peaked at $2.2M in Q1 2024. 156 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Vista Investment Partners held 42,368 shares of Pfizer worth $1.21M as of Q3 2026.
  • Vista Investment Partners sold 14,027 Pfizer shares in Q3 2026, an estimated $373K.
  • Pfizer made up 0.31% of Vista Investment Partners's portfolio in Q3 2026, its #75 holding.
  • Vista Investment Partners first reported a position in Pfizer in Q4 2023 and has held it in 12 quarters since.
  • Vista Investment Partners's Pfizer position peaked at $2.2M in Q1 2024.
  • 156 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Vista Investment Partners's 13F filing for Q3 2026, filed 8 Oct 2026.